Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2024 May 5:2024.05.03.24306699. [Version 1] doi: 10.1101/2024.05.03.24306699

Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults, a randomized, parallel arm, double-blind, placebo-controlled, pilot study

Brianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, Sawyer Peralta, Stephanie Roa-Diaz, Laura Alexander, Wendie Silverman-Martin, Thelma Y Garcia, Michi Yukawa, Jenifer Morris, Traci M Blonquist, James B Johnson, John C Newman
PMCID: PMC11092707  PMID: 38746215

Abstract

Objectives

Ketone bodies are endogenous metabolites produced during fasting or a ketogenic diet that have pleiotropic effects on aging pathways. Ketone esters (KEs) are compounds that induce ketosis without dietary changes, but KEs have not been studied in an older adult population. The primary objective of this trial was to determine tolerability and safety of KE ingestion in older adults.

Design

Randomized, placebo-controlled, double-blinded, parallel-arm trial, with a 12-week intervention period ( NCT05585762 ).

Setting

General community, Northern California, USA.

Participants

Community-dwelling older adults, independent in activities of daily living, with no unstable acute medical conditions (n=30) were randomized and n=23 (M= 14, F=9) completed the protocol.

Intervention

Participants were randomly allocated to consume either KE (bis-octanoyl (R)-1,3-butanediol) or a taste, appearance, and calorie-matched placebo (PLA) containing canola oil.

Measurements

Tolerability was assessed using a composite score from a daily log for 2-weeks, and then via a bi-weekly phone interview. Safety was assessed by vital signs and lab tests at screening and weeks 0, 4 and 12, along with tabulation of adverse events.

Results

There was no difference in the prespecified primary outcome of proportion of participants reporting moderate or severe nausea, headache, or dizziness on more than one day in a two-week reporting period (KE n =2 (14.3% [90% CI = 2.6 – 38.5]); PLA n=1 (7.1% [90% CI = 0.4 – 29.7]). Dropouts numbered four in the PLA group and two in the KE group. A greater number of symptoms were reported in both groups during the first two weeks; symptoms were reported less frequently between 2 – 12 weeks. There were no clinically relevant changes in safety labs or vital signs in either group.

Conclusions

This KE was safe and well-tolerated in healthy older adults. These results provide a foundation for use of KEs in aging research.

Highlights

  • Ketones esters induce ketosis without dietary changes and may target aging biology

  • Studies of ketone esters were limited in duration and focused on younger adults

  • We found ketone esters were safe and tolerable for 12 weeks in healthy older adults

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES